Effectiveness of a Web and Mobile Guided Psychological Intervention for Depressive Symptoms in Turkey
- Conditions
- Depressive Symptoms
- Interventions
- Behavioral: Her Sey Kontrol Altinda (HSKA)
- Registration Number
- NCT03754829
- Lead Sponsor
- Burçin Ünlü İnce
- Brief Summary
The aim of this study is to test the clinical effects of a web and mobile application of guided Problem Solving Therapy for depressive symptoms among the general population in Turkey.
- Detailed Description
In Turkey, there are serious deficiencies in mental health care. Among these, undertreatment of mentally ill patients, lack of psychologists and inadequate psychosocial and rehabilitation options for patients and their relatives are important prohibiting factors that reduce patients' outreach for getting help. While depression is highly prevalent (4.4%), only a small number of people seek professional help (18%) in Turkey. Innovative solutions are needed to overcome this treatment gap. Online Problem-Solving Therapy (PST) is a brief intervention proven to be effective in the treatment of depression, although little is known about its clinical effects in Turkey.
The aim of this study is to test the clinical effects of a web and mobile application of PST for depressive symptoms among the general population in Turkey.
Participants will be recruited through announcements in social media and the Middle East Technical University. A randomized controlled trial with a sample size of 444 participants randomized across three groups will be utilized. The first experimental group will receive direct access to the web version of the intervention; the second experimental group will receive direct access to the mobile app of the intervention as well as automated supportive text messages based on PST. The control group consists of a wait-list and for ethical reasons, participants in this group will gain access to the intervention (either web or mobile application) four months after the baseline. The intervention is based on an existing PST for the Turkish population, "Her Sey Kontrol Altinda" (HSKA).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 444
- Turkish participants living in Turkey are eligible if the applicants are aged between 18-55 years and have mild to moderate depressive symptoms (Beck Depression Inventory-II score between 10 and 29).
- Participants will be excluded if they have a BDI-II score above 29, or a medium-to- high suicidal risk (according to the MINI-International Neuropsychiatric Interview) and are advised to contact a psychiatrist or clinical psychologist.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description HSKA - Web Group Her Sey Kontrol Altinda (HSKA) The first experimental group will receive direct access to the web version of HSKA. HSKA - Mobile Group Her Sey Kontrol Altinda (HSKA) The second experimental group will receive direct access to the mobile app of HSKA as well as automated supportive text messages based on PST.
- Primary Outcome Measures
Name Time Method Change on Beck Depression Inventory-II Screening; baseline, 6-8 weeks after baseline and 4 months after baseline Depressive symptoms
- Secondary Outcome Measures
Name Time Method Change on Penn State Worry Questionnaire (PSWQ) baseline, 6-8 weeks after baseline and 4 months after baseline The PSWQ will be used to measure pathological worry. It has 16 items in total. Each item can be scored on a five-point scale from 1 (not at all typical of me) to 5 (very typical of me), with a total score varying from 16 to 80. Higher scores indicating greater worry.
Satisfaction with the intervention questionnaire 6-8 weeks after baseline only in the two experimental groups Participants will be asked about each module to define their satisfaction with the module concerned ('Was this lesson useful to you?'). The answers can be rated on a 5-point Likert scale from 1 (not at all) to 5 (very useful).
Change on State-Trait Anxiety Inventory (STAI) baseline, 6-8 weeks after baseline and 4 months after baseline Anxiety symptoms
Change on Perceived Stress Scale (PSS) baseline, 6-8 weeks after baseline and 4 months after baseline The PSS will be used to measure the perception of stress. It consists of 10 items for which the total score range is 0-40. Each item is rated on a five-point scale, from 0 (never) to 4 (very often). Higher scores indicating greater stress.
Change on General Self-Efficacy Scale (GSE) baseline, 6-8 weeks after baseline and 4 months after baseline The GSE is a measure to assess self-efficacy beliefs. It contains 10 items, which are rated on a four-point scale from 1 (not at all true) to 5 (exactly true). The total score varies from 10 to 50. Higher scores indicating greater self-efficacy beliefs.
Change on EuroQol-5D-5L (EQ-5D-5L) baseline, 6-8 weeks after baseline and 4 months after baseline EQ-5D-5L will be used to measure quality of life. It consists of 5 items each measuring different dimensions of health status (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). The items are rated on a five-point scale from level 1 to level 5 (no problems; slight, moderate; severe and extreme problems). All the answers to each item are combined resulting in 3125 possible health states, ranging from 11111 (full health) to 55555 (worst health). Furthermore, there is a visual analogue scale (EQ-VAS) measuring a global rating of self-perceived health. This is scored by 0 (the worst health you can imagine) to 100 (the best health you can imagine).
Trial Locations
- Locations (1)
Middle East Technical University
🇹🇷Çankaya, Ankara, Turkey